LogicBio Therapeutics, Inc. Made Headway

Mon, Oct 03, 2022 at 07:54 PM
LogicBio Therapeutics, Inc. Made Headway

LogicBio Therapeutics, Inc. (LOGC:NASDAQ) soared at $2.01, representing a gain of 637.6%. On Mon, Oct 03, 2022, LOGC:NASDAQ touched a New 2-Week High of $2.01. The stock appeared on our News Catalysts scanner on Mon, Oct 03, 2022 at 06:50 PM in the 'ACQUISITION' category. From Mon, Sep 19, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days

About LogicBio Therapeutics, Inc. (LOGC:NASDAQ)

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.